department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Aldeyra Therapeutics, Inc. ($ALDX) · pharmadog

PUBLIC COMPANY

$ALDXAldeyra Therapeutics, Inc.

Lexington, MA, USupdated 2mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Retinitis Pigmentosa (Retinitis)

Dihydrofolate reductase

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Aldeyra Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$ALDX

SEC CIK

0001341235

country

US

source

sec_tickers

mentioned in

0news items

entity-linker matched

Active trials

phase2A Study in Subjects With Retinitis Pigmentosacompletedn=8
phase3A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphomarecruitingn=20
phase3A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Diseasecompletedn=116
phase2A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)completedn=4
phase3A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Diseasecompletedn=757
phase3A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Diseasecompletedn=421
phase3The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathycompletedn=106
phase3A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Diseasecompletedn=132

more trials →

Data sources

last refreshed 12m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

$ALDX

Insider activity

source: SEC Form 4

open-market buys + sells

Mar 19, 26BUYDOUGLAS RICHARD· director70,000 sh @ $1.40$98K↗
Mar 18, 26BUYAlfieri Michael· Principal Financial Officer5,000 sh @ $1.42$7K↗

routine RSU / option mechanics (2)

Mar 27, 26grantBrady Todd C · President and CEO1,880,510 sh
Mar 27, 26grantBrady Todd C · President and CEO632,318 sh

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?